A fragile global supply chain has contributed to widespread drug shortages but new technology, including predictive analytics and decentralised pharmaceutical manufacturing platforms, could be the keys to addressing this challenge.
A fragile global supply chain has contributed to widespread drug shortages but new technology, including predictive analytics and decentralised pharmaceutical manufacturing platforms, could be the keys to addressing this challenge.